Becton, Dickinson and Company
BDX · NYSE
Bulios Fair Price
$230.86
26.4% upside
Current Price
$182.6
According to Bulios Fair Price, BDX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Becton, Dickinson and Company (BDX) is an American company operating in the field of healthcare technologies and medical devices. The company specializes in the development, manufacturing, and distribution of a wide range of products for diagnostics, therapy, and treatment in various healthcare areas. Its products include items such as needles, syringes, infectious disease diagnostic tests, diabetic products, and other medical devices. Becton, Dickinson and Company is known for its innovative technologies and high-quality products that contribute to improving patient care and enhancing the efficiency of medical procedures. The company operates globally and serves as a partner for healthcare institutions, hospitals, and medical professionals worldwide. Shares of Becton, Dickinson and Company (BDX) may represent an interesting investment opportunity for investors monitoring the healthcare sector and innovations in medical technologies.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas E. Polen Jr.
Employees
72,000
Headquarters
Franklin Lakes
Upcoming events
Earnings
Upcoming earnings report